UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors

Blood, 2007-01, Vol.109 (2), p.610-612

2007

Volltextzugriff (PDF)

The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status

Blood, 2014-01, Vol.123 (1), p.121-125

2014

Volltextzugriff (PDF)

Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A

Haematologica (Roma), 2019-08, Vol.104 (8), p.e369-e372

2019

Volltextzugriff (PDF)

Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?

Pharmaceutics, 2020-04, Vol.12 (4), p.380

2020

Volltextzugriff (PDF)

Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi

Circulation (New York, N.Y.), 2017-08, Vol.136 (7), p.646-660

2017

Volltextzugriff (PDF)

Genotype-dependent response to desmopressin in hemophilia A and proposal of a predictive response score

Thrombosis and haemostasis, 2024-05

2024

Volltextzugriff (PDF)

rFVIII‐Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings

European journal of clinical investigation, 2022-10, Vol.52 (10), p.e13824-n/a

2022

Volltextzugriff (PDF)

Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation

Haematologica (Roma), 2008-01, Vol.93 (1), p.83-89

2008

Volltextzugriff (PDF)

Congenital Haemostasis Disorders and Urology Surgery: Is It Safe?

Journal of clinical medicine, 2024-04, Vol.13 (8), p.2357

2024

Volltextzugriff (PDF)

Thermodynamic Analysis of the Interaction of Factor VIII with von Willebrand Factor

Biochemistry (Easton), 2012-05, Vol.51 (20), p.4108-4116

2012

Volltextzugriff (PDF)

Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter

Haematologica (Roma), 2013-10, Vol.98 (10), p.1650-1655

2013

Volltextzugriff (PDF)

Acquired von Willebrand disease in Jarvik 2000 recipients: A single center experience

International journal of cardiology, 2012-08, Vol.159 (1), p.57-58

2012

Volltextzugriff (PDF)

Impact of Alcohol Consumption on the Outcome of Ischemic Stroke and Thrombolysis: Role of the Hepatic Clearance of Tissue-Type Plasminogen Activator

Stroke (1970), 2015-06, Vol.46 (6), p.1641-1650

2015

Volltextzugriff (PDF)

Mannose-sensitive receptors mediate the uptake of factor VIII therapeutics by human dendritic cells

Journal of allergy and clinical immunology, 2012-04, Vol.129 (4), p.1172-1173

2012

Volltextzugriff (PDF)

Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs

Journal of thrombosis and haemostasis, 2024-07

2024

Volltextzugriff (PDF)

Proteolytic antibodies activate factor IX in patients with acquired hemophilia

Blood, 2011-02, Vol.117 (7), p.2257-2264

2011

Volltextzugriff (PDF)

Induction of heme oxygenase-1 in factor VIII–deficient mice reduces the immune response to therapeutic factor VIII

Blood, 2010-04, Vol.115 (13), p.2682-2685

2010

Volltextzugriff (PDF)

Cellular Viewpoint of Anti-FVIII Immune Response in Hemophilia A

Clinical reviews in allergy & immunology, 2009-10, Vol.37 (2), p.105-113

2009

Volltextzugriff (PDF)

Endocytic receptor for pro-coagulant factor VIII: relevance to inhibitor formation

Thrombosis and haemostasis, 2010-12, Vol.104 (6), p.1093-1098

2010

Volltextzugriff (PDF)

The role of VWF in the immunogenicity of FVIII

Thrombosis research, 2008, Vol.122, p.S3-S6

2008

Volltextzugriff (PDF)

Octreotide for recurrent intestinal bleeding due to ventricular assist device

Asian cardiovascular & thoracic annals, 2014-03, Vol.22 (3), p.350-352

2014

Volltextzugriff (PDF)

Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development

Journal of thrombosis and haemostasis, 2007-07, Vol.5 (7), p.1469-1476

2007

Volltextzugriff (PDF)

Drug‐associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-01, Vol.29 (1), p.186-192

2023

Volltextzugriff (PDF)

Haematological complications of cystinosis

European journal of haematology, 2015-02, Vol.94 (2), p.187-187

2015

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors

The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status

Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A

Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?

Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi

Genotype-dependent response to desmopressin in hemophilia A and proposal of a predictive response score

rFVIII‐Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings

Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation

Congenital Haemostasis Disorders and Urology Surgery: Is It Safe?

Thermodynamic Analysis of the Interaction of Factor VIII with von Willebrand Factor

Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter

Acquired von Willebrand disease in Jarvik 2000 recipients: A single center experience

Impact of Alcohol Consumption on the Outcome of Ischemic Stroke and Thrombolysis: Role of the Hepatic Clearance of Tissue-Type Plasminogen Activator

Mannose-sensitive receptors mediate the uptake of factor VIII therapeutics by human dendritic cells

Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs

Proteolytic antibodies activate factor IX in patients with acquired hemophilia

Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A

Induction of heme oxygenase-1 in factor VIII–deficient mice reduces the immune response to therapeutic factor VIII

Cellular Viewpoint of Anti-FVIII Immune Response in Hemophilia A

Endocytic receptor for pro-coagulant factor VIII: relevance to inhibitor formation

The role of VWF in the immunogenicity of FVIII

Octreotide for recurrent intestinal bleeding due to ventricular assist device

Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development

Drug‐associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database

Haematological complications of cystinosis

Suchergebnisse filtern